Our Space: Building Community for Young Adults with Mitochondrial Disease

November 20, 2024 00:15:10
Our Space: Building Community for Young Adults with Mitochondrial Disease
Energy in Action by MitoAction
Our Space: Building Community for Young Adults with Mitochondrial Disease

Nov 20 2024 | 00:15:10

/

Show Notes

In this episode of Energy in Action, host Marcy Young sits down with Alex Salser, a passionate advocate and volunteer with MitoAction, to discuss her inspiring journey of overcoming challenges with LCHAD, a mitochondrial disease. Alex shares her recent milestone of graduating college in just three years, despite numerous hospitalizations, and how she continues to fight for the life she wants to live.

Alex also introduces Our Space, the young adult support group she leads through MitoAction, designed to help those aged 18 to 30 connect, share, and navigate life with mitochondrial disease. From relationships and careers to education and insurance, Our Space fosters understanding, encouragement, and friendship for those facing similar challenges.

Resources and Ways to Connect with MitoAction:

Tune in to hear Alex’s incredible story and learn how Our Space is making a difference for young adults in the mitochondrial disease community.

Other Episodes

Episode

November 19, 2025 00:57:10
Episode Cover

Making Nutrition Work for You: Planning Meals with Mito in Mind

Donna DiVito is a registered dietitian at the Children's Hospital of Philadelphia and a returning guest on Energy in Action. In this episode, host...

Listen

Episode 65

September 21, 2022 00:33:25
Episode Cover

Tara Zier - Stiff Person Syndrome Research Foundation and Finding Your Purpose

  PARENTS AS RARE - EPISODE 065 Tara Zier - Stiff Person Syndrome Research Foundation and Finding Your Purpose   Tara Zier is a rare disease...

Listen

Episode

January 21, 2026 00:29:48
Episode Cover

What PFDD Meetings Mean for the Mito Community

Patient-Focused Drug Development (PFDD) meetings are one of the most powerful advocacy tools available to rare disease communities—but most patients have never heard of...

Listen